Increasing HPV Vaccination in Community-Based Pediatric Practices
2 other identifiers
interventional
420
1 country
1
Brief Summary
The central goal of this study is to identify the optimal approach to implementing an evidence-based practice facilitation (PF) intervention for the uptake and completion of HPV vaccine among adolescents receiving care in the community, guided by implementation science theory. AIM 1: Determine the clinical effectiveness and cost-effectiveness of two modalities for delivering a multi-component PF intervention to increase HPV vaccination initiation and completion in community-based pediatric practices. The investigators will compare the traditional In-person Coaching PF modality to a lower-resource Web-Based Coaching PF modality. The primary patient outcome is HPV vaccination. The investigators will also examine and compare the sustainability of practice changes on vaccination rates and the effects over time for each intervention modality. AIM 2. Understand mechanisms of why the PF intervention may work better for some pediatric practices than others for HPV vaccination. The investigators will examine theory-based determinants at the organizational, provider, and patient levels that may mediate (explain) or moderate (change) the effects of the PF intervention on vaccination outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2017
CompletedFirst Posted
Study publicly available on registry
January 16, 2018
CompletedStudy Start
First participant enrolled
February 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2021
CompletedDecember 5, 2023
December 1, 2023
3 years
December 20, 2017
December 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Age-appropriate completion rate (ages 13-17)
Percentage of active patients ages 13-17 who completed the HPV vaccine series before 13th birthday
Annually, up to 3 years post baseline
Secondary Outcomes (9)
Age-appropriate initiation rate (ages 13-17)
Monthly, up to 36 months post baseline
Age-appropriate completion rate (at age 13)
Monthly, up to 36 months post baseline
Age-appropriate initiation rate (at age 13)
Monthly, up to 36 months post baseline
Overall completion rate (ages 13-17)
Monthly, up to 36 months post baseline
Overall initiation rate (ages 13-17)
Monthly, up to 36 months post baseline
- +4 more secondary outcomes
Other Outcomes (4)
Documented recommendation rate (well visits)
Monthly, up to 36 months post baseline
Documented recommendation rate (all visits)
Monthly, up to 36 months post baseline
Bundling adolescent vaccines rate
Monthly, up to 36 months post baseline
- +1 more other outcomes
Study Arms (2)
Web-Based Coaching
EXPERIMENTALWeb-based delivery of practice facilitation for HPV vaccine
In-Person Coaching
EXPERIMENTALIn-person delivery of practice facilitation for HPV vaccine
Interventions
The practice facilitation intervention provides coaching support to pediatric practices to guide them through quality improvement projects to increase HPV vaccination rates.
Eligibility Criteria
You may qualify if:
- All providers and staff at each practice
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pamela Hulllead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
Related Publications (1)
Chang RS, Shing JZ, Erves JC, Du L, Koyama T, Deppen S, Rentuza AB, McAfee C, Stroebel C, Cates J, Harnack L, Andrews D, Bramblett R, Hull PC. Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine. BMC Med Inform Decis Mak. 2022 Dec 22;22(1):339. doi: 10.1186/s12911-022-02083-2.
PMID: 36550466DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pamela C Hull, PhD
Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention, it is not possible to blind the practices or study staff to study arm allocation. To minimize bias, allocation will be masked until after baseline data collection of outcome measures, when it is time for each practice to initiate the intervention.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 20, 2017
First Posted
January 16, 2018
Study Start
February 21, 2018
Primary Completion
February 28, 2021
Study Completion
February 28, 2021
Last Updated
December 5, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Upon request
- Access Criteria
- Qualified researcher with IRB approval
Data collected from providers and staff (surveys and interviews) will be made available to other researchers upon request. All individual identifiers will be stripped to ensure confidentiality and privacy of study participants.